Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- New Kalorama Report Pegs Clinical Lab Services Market at 168BN May 18, 2023
- WHO Reports Lowered Threat Level of COVID-19; What Does it Mean for Testing? May 9, 2023
- SDi Releases Flagship Market Research Report on Analytical and Life Science Instruments: The Global Assessment Report May 3, 2023
- Despite Declines, COVID-19 Still a Large IVD Market May 1, 2023
- Single Cell Genomics Market Reaches $1 Billion April 27, 2023
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Brazil and Mexico Lead IVD Investments in Latin America
Still Room to Grow in Infectious Disease IVD
Per Kalorama Information’s World Infectious Disease report: Opportunities for infectious disease testing products vary widely between the developed and developing countries, according to our most recent report on infectious disease world markets. With favorable access to a complete range of tests and the operation of advanced medical delivery systems that reach most residents and in spite of making […]
China: Molecular Point-of-Care’s International Market to Watch
Molecular point-of-care (mPOC) is a multi-billion dollar market with expanding international intrigue. Though the mPOC market is led by North America and Europe, the Asia-Pacific region makes up 10% of the market’s worldwide sales, with China positioned as a burgeoning power within the APAC. Kalorama Information, a leading medical market research firm, covers mPOC’s global […]
Veterinary Diagnostic Testing for Pets and Other Animals Will Grow Globally to $5.8 Billion in 2027
Where the pets go, so go the profits. This is true not just for mainstream pet products (such as food and toys) or services (such as grooming and boarding), but extends to veterinary pet healthcare, most notably veterinary diagnostic testing. Indeed, the global veterinary diagnostic market is forecast to grow to approximately $5.8 billion in […]
Growth in Molecular Diagnostics, Beyond COVID-19
COVID-19 is not over, but test sales are clearly on the decline, and IVD companies for the most part have adopted a focus on other test areas to beat the negative trend. Abbot, Roche, Hologic and Quest are among the diagnostic testing companies that have reported 2022 results with COVID-19 losses softened by gains in […]
Expect More Testing Performed at Physician Office Lab Venues: Report
The IVD market follows patients where technologies allow. There’s no greater evidence for need for IVD product makers to find a market in physician office labs than the declining hospital bed count. With declining hospital bed in developed countries and slow growth in hospital bed volume even in developing nations, it makes sense that more […]
$1.3 Billion Liquid Biopsy Market the Present and Future of Clinical Oncology
The global market for liquid biopsy diagnostic tests reached an estimated $1,267 million ($1.3 billion) in 2022, led by demand for diagnostics in guiding therapeutic decisions. The market is forecast to almost triple over the next several years, approaching $3.9 billion in 2027, according to medical market research firm Kalorama Information in the new report […]
NGS in Molecular Diagnostics
The first NGS system was approved for clinical use by the FDA only in 2013. Hence, the market segment is quite new, even though a significant industry exists for LDTs performed as testing services on NGS platforms by certified clinical labs. The current IVD market available in clinical sequencing consists largely of sales of NGS […]
2023 Healthcare Trend: Growth in $21 Billion Molecular Diagnostics Market
Future molecular IVD sales buoyed by COVID-19, infectious diseases, and sexually transmitted infections There is a market in excess of $21 billion for molecular testing technologies, reveals medical market research publisher Kalorama Information in The World Market for Molecular Diagnostics Tests, 11th Edition, a recent report added to the firm’s Knowledge Center subscription. The majority […]
14 Companies Dominate Med Device Market: Report
The market for medical devices is valued at $570 billion in 2022, according to Kalorama Information’s 12th report on the market since 2009. It grew 2.7% last year, and Kalorama believes it will grow average 3.4% next five years. Expect increasing revenue growth for 2022 as markets continue to stabilize. In 2023 and forward, growth […]